Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer

HIGHLIGHTS

  • who: Aparna Shinde from the IACUC approval from Purdue University was received for conducting all in vivo assays, parental and HME2-BM cells were engrafted into the duct of the second mammary fat pad of, week old female, NSG mice (, u00d7 u00ad, , u00b5l, mouse). When tumors reached , u00admm3, mice an oral gavage of neratinib (, mg/ kg/q.o.d). Neratinib was first solubilized in DMSO, and, .25% Tween-80, .5% carboxymethyl cellulose solution was used for oral gavage at a final DMSO concentration of, %. In separate experiments, female, week old NSG mice were engrafted with HME2-BM . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?